New guidance from ACP and recent trials do not support the use of hydroxychloroquine for COVID-19, and a pharmacokinetic analysis showed potential problems with lopinavir/ritonavir therapy.
A British study highlighted the disproportionate effect of COVID-19 on black pregnant women, and articles by physicians urged action against racism and racial disparities.
Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and the authorization for use of remdesivir was expanded.
Both ACP and The BMJ completed evidence reviews and issued recommendations on use of certain drugs for COVID-19. Another article warned about Strongyloides hyperinfection, a potentially dangerous side effect of dexamethasone for some patients.
Medical societies addressed appropriate resuscitation and chest imaging practices for patients with COVID-19, as well as general use of extracorporeal membrane oxygenation (ECMO).
The College identified five necessary elements that must be in place to ease restrictions, groups issued a joint statement on resuming elective surgeries, and CMS released guidance on resuming essential care for patients without COVID-19 symptoms in
Recent papers addressed how to treat strokes and addiction during a pandemic, and ACP issued statements supporting physicians who bring their own personal protective equipment or speak out about unsafe conditions.
Studies show the Bronx was hit much harder by COVID-19 than Manhattan, and many front-line health care workers have risk factors and lack insurance. ACP and other experts call for action to combat disparities.
Remdesivir showed limited benefits, antibiotics have been overused, and intubation timing doesn't matter, but postdischarge outcomes were reassuring and infectious diseases experts offered guidance on the use of antibody tests in recent COVID-19 news
A new CHEST guideline supports standard-dose anticoagulant thromboprophylaxis, while authors of two recent studies of hypercoagulability called for higher doses.